Inventor
EDELMAN JEFFREY L
US22 patents
⚠️ This page may combine multiple inventors who share the name “EDELMAN JEFFREY L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALLERGAN INC
17 patentsUS7771742B2Aug 10, 2010
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
ALLERGAN INC47 citations97
US8968766B2Mar 3, 2015
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
ALLERGAN INC19 citations91
US10076492B2Sep 18, 2018
Biodegradable intravitreal tyrosine kinase implants
ALLERGAN INC4 citations84
US9233070B2Jan 12, 2016
Biodegradable intravitreal tyrosine kinase implants
ALLERGAN INC6 citations84
US9433631B2Sep 6, 2016
4-pregenen-11β-17-21-triol-3,20-dione derivatives
ALLERGAN INC3 citations83
US8906892B2Dec 9, 2014
4-pregenen-11β-17-21-triol-3,20-dione derivatives
ALLERGAN INC5 citations83
US9259429B2Feb 16, 2016
Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues
ALLERGAN INC3 citations82
US8865691B2Oct 21, 2014
Pharmaceutical compositions and methods of use 4-pregenen-11β-17-21-triol-3,20-dione derivatives
ALLERGAN INC4 citations82
US10881608B2Jan 5, 2021
Biodegradable intravitreal tyrosine kinase implants
ALLERGAN INC1 citations73
US10188665B2Jan 29, 2019
Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues
ALLERGAN INC1 citations71
US7749530B2Jul 6, 2010
Kinase inhibitors
ALLERGAN INC5 citations62
US9717743B2Aug 1, 2017
Pharmaceutical compositions and methods of use of 4-pregenen-11β-17-21-triol-3,20-dione derivatives
ALLERGAN INC1 citations61
US9820995B2Nov 21, 2017
Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues
ALLERGAN INC1 citations60
US8383825B2Feb 26, 2013
Kinase inhibitors
ALLERGAN INC0 citations52
US10493082B2Dec 3, 2019
4-pregenen-11β-17-21-triol-3,20-dione derivatives
ALLERGAN INC0 citations51
US10188667B2Jan 29, 2019
Pharmaceutical compositions and methods of use of 4-pregenen-11β-17-21-triol-3,20-dione derivatives
ALLERGAN INC0 citations51
US8969583B2Mar 3, 2015
3-phenyl-5-ureidoisothiazole-4-carboximide and 3-amino-5-phenylisothiazole derivatives as kinase inhibitors
ALLERGAN INC0 citations38
EDELMAN JEFFREY L
3 patentsUS8512738B2Aug 20, 2013
Biodegradable intravitreal tyrosine kinase implants
EDELMAN JEFFREY L89 citations96
US8062657B2Nov 22, 2011
Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues
EDELMAN JEFFREY L30 citations93
US8840872B2Sep 23, 2014
Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues
EDELMAN JEFFREY L6 citations81